T1 Mapping and Interstitial Fibrosis as a Marker for Heart Failure in Hypertrophic Cardiomyopathy
Circulation: Cardiovascular Imaging
FEBRUARY 17, 2025
Circulation: Cardiovascular Imaging, Ahead of Print.
Circulation: Cardiovascular Imaging
FEBRUARY 17, 2025
Circulation: Cardiovascular Imaging, Ahead of Print.
Circulation: Cardiovascular Imaging
AUGUST 19, 2024
Circulation: Cardiovascular Imaging, Volume 17, Issue 8 , Page e017160, August 1, 2024.
Circulation: Cardiovascular Imaging
JULY 15, 2024
Circulation: Cardiovascular Imaging, Volume 17, Issue 7 , Page e017137, July 1, 2024.
Circulation: Cardiovascular Imaging
APRIL 3, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Microvascular obstruction (MVO) is associated with heart failure (HF) following ST-segmentelevation myocardial infarction.
Circulation: Cardiovascular Imaging
NOVEMBER 2, 2023
Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e000081, November 1, 2023. Advanced disease presents as heart failure and cardiac arrhythmias conferring poor prognosis.
Circulation: Cardiovascular Imaging
MARCH 21, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Patients with paradoxical low-flow, low-gradient severe aortic stenosis exhibit low transvalvular flow rate (Q), while maintaining preserved left ventricular ejection fraction. Subgroups were based on MR severity (severe and nonsevere).
Circulation: Cardiovascular Imaging
JANUARY 13, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:In patients with heart failure with preserved ejection fraction (HFpEF), the impact of type 2 diabetes (T2D) on left ventricular global longitudinal strain (LV GLS) and its prognostic implications remains unclear.
Let's personalize your content